The parkinson's disease-related protein dj-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity

Sara Batelli, Roberto William Invernizzi, Alessandro Negro, Eleonora Calcagno, Serena Rodilossi, Gianluigi Forloni, Diego Albani

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Dopaminergic degeneration is a major finding in brains of patients with Parkinson's disease (PD), together with Lewy bodies, intraneuronal inclusions mainly composed of the fibrillogenic protein -synuclein (-syn). The familial-PD-related protein DJ-1 was reported to reduce dopaminergic degeneration triggered by -syn or by the dopaminergic-selective neurotoxin 6-hydroxydopamine (6-OHDA). Objective: The aim was to further investigate the role of DJ-1 in dopaminergic degeneration and to see whether a cell-permeable recombinant form of DJ-1 (TAT-DJ-1) could restore dopamine depletion in vivo, thus representing an innovative therapeutic approach. Methods: We developed in vitro (PC12/TetOn cells and mouse primary mesencephalic neurons) and in vivo models [including DJ-1 knockout (-/-) mice] to investigate DJ-1 in dopaminergic degeneration. Results: We found that in PC12/TetOn cells overexpressing -syn with the familial-PD linked mutation A30P, DJ-1 silencing increased -syn (A30P) toxicity. Primary mesencephalic neurons from DJ-1 (-/-) mice were more vulnerable to a cell-permeable form of -syn (TAT-syn) and to 6-OHDA. Intrastriatally administered TAT-DJ-1 reduced 6-OHDA toxicity in vivo in C57BL/6 mice. Finally, when we injected TAT-syn (A30P) in the striatum of DJ-1 (-/-) animals, dopamine was depleted more than in the control strain. Conclusion: DJ-1 appears to have a protective role against dopaminergic degeneration triggered by -syn or 6-OHDA, reinforcing the possible therapeutic importance of this protein in PD.

Original languageEnglish
Pages (from-to)13-23
Number of pages11
JournalNeurodegenerative Diseases
Volume15
Issue number1
DOIs
Publication statusPublished - Mar 6 2015

Fingerprint

alpha-Synuclein
Oxidopamine
Dopaminergic Neurons
Parkinson Disease
Cultured Cells
PC12 Cells
Proteins
Dopamine
Synucleins
Lewy Bodies
Neurons
Neurotoxins
Inbred C57BL Mouse
Knockout Mice
Mutation
Brain
Therapeutics

Keywords

  • -Synuclein
  • 6-Hydroxydopamine
  • DJ-1 protein
  • Parkinson's disease
  • Therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

The parkinson's disease-related protein dj-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity. / Batelli, Sara; Invernizzi, Roberto William; Negro, Alessandro; Calcagno, Eleonora; Rodilossi, Serena; Forloni, Gianluigi; Albani, Diego.

In: Neurodegenerative Diseases, Vol. 15, No. 1, 06.03.2015, p. 13-23.

Research output: Contribution to journalArticle

@article{eec58a16eb6443719449053e758cf313,
title = "The parkinson's disease-related protein dj-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity",
abstract = "Background: Dopaminergic degeneration is a major finding in brains of patients with Parkinson's disease (PD), together with Lewy bodies, intraneuronal inclusions mainly composed of the fibrillogenic protein -synuclein (-syn). The familial-PD-related protein DJ-1 was reported to reduce dopaminergic degeneration triggered by -syn or by the dopaminergic-selective neurotoxin 6-hydroxydopamine (6-OHDA). Objective: The aim was to further investigate the role of DJ-1 in dopaminergic degeneration and to see whether a cell-permeable recombinant form of DJ-1 (TAT-DJ-1) could restore dopamine depletion in vivo, thus representing an innovative therapeutic approach. Methods: We developed in vitro (PC12/TetOn cells and mouse primary mesencephalic neurons) and in vivo models [including DJ-1 knockout (-/-) mice] to investigate DJ-1 in dopaminergic degeneration. Results: We found that in PC12/TetOn cells overexpressing -syn with the familial-PD linked mutation A30P, DJ-1 silencing increased -syn (A30P) toxicity. Primary mesencephalic neurons from DJ-1 (-/-) mice were more vulnerable to a cell-permeable form of -syn (TAT-syn) and to 6-OHDA. Intrastriatally administered TAT-DJ-1 reduced 6-OHDA toxicity in vivo in C57BL/6 mice. Finally, when we injected TAT-syn (A30P) in the striatum of DJ-1 (-/-) animals, dopamine was depleted more than in the control strain. Conclusion: DJ-1 appears to have a protective role against dopaminergic degeneration triggered by -syn or 6-OHDA, reinforcing the possible therapeutic importance of this protein in PD.",
keywords = "-Synuclein, 6-Hydroxydopamine, DJ-1 protein, Parkinson's disease, Therapy",
author = "Sara Batelli and Invernizzi, {Roberto William} and Alessandro Negro and Eleonora Calcagno and Serena Rodilossi and Gianluigi Forloni and Diego Albani",
year = "2015",
month = "3",
day = "6",
doi = "10.1159/000367993",
language = "English",
volume = "15",
pages = "13--23",
journal = "Neurodegenerative Diseases",
issn = "1660-2854",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - The parkinson's disease-related protein dj-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity

AU - Batelli, Sara

AU - Invernizzi, Roberto William

AU - Negro, Alessandro

AU - Calcagno, Eleonora

AU - Rodilossi, Serena

AU - Forloni, Gianluigi

AU - Albani, Diego

PY - 2015/3/6

Y1 - 2015/3/6

N2 - Background: Dopaminergic degeneration is a major finding in brains of patients with Parkinson's disease (PD), together with Lewy bodies, intraneuronal inclusions mainly composed of the fibrillogenic protein -synuclein (-syn). The familial-PD-related protein DJ-1 was reported to reduce dopaminergic degeneration triggered by -syn or by the dopaminergic-selective neurotoxin 6-hydroxydopamine (6-OHDA). Objective: The aim was to further investigate the role of DJ-1 in dopaminergic degeneration and to see whether a cell-permeable recombinant form of DJ-1 (TAT-DJ-1) could restore dopamine depletion in vivo, thus representing an innovative therapeutic approach. Methods: We developed in vitro (PC12/TetOn cells and mouse primary mesencephalic neurons) and in vivo models [including DJ-1 knockout (-/-) mice] to investigate DJ-1 in dopaminergic degeneration. Results: We found that in PC12/TetOn cells overexpressing -syn with the familial-PD linked mutation A30P, DJ-1 silencing increased -syn (A30P) toxicity. Primary mesencephalic neurons from DJ-1 (-/-) mice were more vulnerable to a cell-permeable form of -syn (TAT-syn) and to 6-OHDA. Intrastriatally administered TAT-DJ-1 reduced 6-OHDA toxicity in vivo in C57BL/6 mice. Finally, when we injected TAT-syn (A30P) in the striatum of DJ-1 (-/-) animals, dopamine was depleted more than in the control strain. Conclusion: DJ-1 appears to have a protective role against dopaminergic degeneration triggered by -syn or 6-OHDA, reinforcing the possible therapeutic importance of this protein in PD.

AB - Background: Dopaminergic degeneration is a major finding in brains of patients with Parkinson's disease (PD), together with Lewy bodies, intraneuronal inclusions mainly composed of the fibrillogenic protein -synuclein (-syn). The familial-PD-related protein DJ-1 was reported to reduce dopaminergic degeneration triggered by -syn or by the dopaminergic-selective neurotoxin 6-hydroxydopamine (6-OHDA). Objective: The aim was to further investigate the role of DJ-1 in dopaminergic degeneration and to see whether a cell-permeable recombinant form of DJ-1 (TAT-DJ-1) could restore dopamine depletion in vivo, thus representing an innovative therapeutic approach. Methods: We developed in vitro (PC12/TetOn cells and mouse primary mesencephalic neurons) and in vivo models [including DJ-1 knockout (-/-) mice] to investigate DJ-1 in dopaminergic degeneration. Results: We found that in PC12/TetOn cells overexpressing -syn with the familial-PD linked mutation A30P, DJ-1 silencing increased -syn (A30P) toxicity. Primary mesencephalic neurons from DJ-1 (-/-) mice were more vulnerable to a cell-permeable form of -syn (TAT-syn) and to 6-OHDA. Intrastriatally administered TAT-DJ-1 reduced 6-OHDA toxicity in vivo in C57BL/6 mice. Finally, when we injected TAT-syn (A30P) in the striatum of DJ-1 (-/-) animals, dopamine was depleted more than in the control strain. Conclusion: DJ-1 appears to have a protective role against dopaminergic degeneration triggered by -syn or 6-OHDA, reinforcing the possible therapeutic importance of this protein in PD.

KW - -Synuclein

KW - 6-Hydroxydopamine

KW - DJ-1 protein

KW - Parkinson's disease

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84924269795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924269795&partnerID=8YFLogxK

U2 - 10.1159/000367993

DO - 10.1159/000367993

M3 - Article

VL - 15

SP - 13

EP - 23

JO - Neurodegenerative Diseases

JF - Neurodegenerative Diseases

SN - 1660-2854

IS - 1

ER -